Antibody-based therapies for COVID-19: Can Europe move faster?
Autoři:
Michel D. Kazatchkine aff001; Michel Goldman aff002; Jean-Louis Vincent aff003
Působiště autorů:
Global Health Center, Graduate Institute, Geneva, Switzerland
aff001; I3h Institute, Université libre de Bruxelles, Brussels, Belgium
aff002; Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium
aff003
Vyšlo v časopise:
Antibody-based therapies for COVID-19: Can Europe move faster?. PLoS Med 17(5): e1003127. doi:10.1371/journal.pmed.1003127
Kategorie:
Perspective
doi:
https://doi.org/10.1371/journal.pmed.1003127
Souhrn
Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus.
Klíčová slova:
Antibodies – Blood plasma – Europe – European Union – Immunology – Respiratory infections – Immunotherapy – Antibody therapy
Zdroje
1. Vincent JL, Taccone FS. Understanding pathways to death in patients with COVID-19. Lancet Respir Med 2020. Published online April 6, 2020.https://doi.org/10.1016/S2213-2600(20)30165-X
2. To K, Tsang O, Leung WS, Tam A, Wu TC, Lung D, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; Published online March 23, 2020. https://doi.org/10.1016/S1473-3099(20)30196-1.
3. Ju B, Zhang Q, Ge X, Wang R, Yu J, Shan S, et al. Potent human neutralizing antibodies elicited by SARS-CoV-2 infection. BioRxiv https://doi.org/10.1101/2020.03.21.990770
4. Bao L, Deng W, Gao H, Xiao C, Liu J, Xue J, et al. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. BioRxiv https://doi.org/10.1101/2020.03.13.990226
5. Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, et al. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis 2015; 11:411–16.
6. Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 2020; Published online March 27, 2020. doi: 10.1001/jama.2020.4783
7. Roback JD, Guarner J. Convalescent plasma to treat Covid-19. JAMA 2020; Published on line March27, 2020. doi: 10.1001/jama.2020.4940 32219429
8. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007; 357: 1450–51 doi: 10.1056/NEJMc070359 17914053
9. Bal C, Herbreteau C, Buchy P, Rith S, Zaid M, Kristanto W et al. Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab’)2 fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study. Lancet Infect Dis 2015; 15:285–92. doi: 10.1016/S1473-3099(14)71072-2 25662592
10. Coughlin MM, Lou G, Martinez O, Masterman SK, Olsen OA, Moksa AA et al. Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse. Virology 2007; 361: 93–102. doi: 10.1016/j.virol.2006.09.029 17161858
11. Mulangu S, Dodd LE, Davey RT et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med 2019; 381:2293–2303 doi: 10.1056/NEJMoa1910993 31774950
Článek vyšel v časopise
PLOS Medicine
2020 Číslo 5
- Antibiotika na nachlazení nezabírají! Jak můžeme zpomalit šíření rezistence?
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Ibuprofen jako alternativa antibiotik při léčbě infekcí močových cest
- Jak a kdy u celiakie začíná reakce na lepek? Možnou odpověď poodkryla čerstvá kanadská studie
Nejčtenější v tomto čísle
- National and regional prevalence of posttraumatic stress disorder in sub-Saharan Africa: A systematic review and meta-analysis
- Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: A population-based cohort study
- Antibody-based therapies for COVID-19: Can Europe move faster?
- The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the Rotterdam Study: A prospective cohort study